Figure 8. MitoQ treatment inhibits phospho-Smad2/3-mediated signalling in the diabetic kidney.
(A) Paraffin-embedded sections were prepared from paraformaldehyde-fixed tissues and stained with anti-phopho-Smad2/3 antibody linked to Alexa Fluor® 488 (green); the nuclei were stained with DAPI (4′,6-diamidino-2-phenylindole; blue). Sections were imaged using Simple PCI software. (B) Images were quantified for phospho-Smad2/3 localization in the nucleus using Simple PCI software. Mean green intensities (n=6, per group) were calculated, analysed by ANOVA and the Newman–Keuls test and expressed (± S.E.M). #P≤0.05.